Comparing Telehealth and In-person Assessments in Glioma Patients Receiving Oral Chemotherapy

Clinical trial NCT06625047 · COMPLETED

Trial details

NCT number: NCT06625047
Sponsor: Mayo Clinic
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Astrocytoma, IDH-Mutant Glioblastoma Glioma Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted

Start date: 2024-10-07
Primary completion: 2025-11-12
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.